Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci

Antimicrob Agents Chemother. 1999 May;43(5):1062-6. doi: 10.1128/AAC.43.5.1062.

Abstract

The relative frequency of 10 determinants of resistance to macrolides, lincosamides, and streptogramins was investigated by PCR in a series of 294 macrolide-, lincosamide-, and/or streptogramin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci isolated in 1995 from 32 French hospitals. Resistance was mainly due to the presence of ermA or ermC genes, which were detected in 259 strains (88%), in particular those resistant to methicillin (78% of the strains). Macrolide resistance due to msrA was more prevalent in coagulase-negative staphylococci (14.6%) than in S. aureus (2.1%). Genes related to linA/linA' and conferring resistance to lincomycin were detected in one strain of S. aureus and seven strains of coagulase-negative staphylococci. Resistance to pristinamycin and quinupristin-dalfopristin was phenotypically detected in 10 strains of S. aureus and in three strains of coagulase-negative staphylococci; it was always associated with resistance to type A streptogramins encoded by vat or vatB genes and occurred in association with erm genes. The vga gene conferring decreased susceptibility to type A streptogramins was present alone in three strains of coagulase-negative staphylococci and in combination with erm genes in 10 strains of coagulase-negative staphylococci. A combination of vga-vgb-vat and ermA genes was found in a single strain of S. epidermidis.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial / genetics*
  • Gene Expression Regulation, Bacterial
  • Genes, Bacterial*
  • Lincosamides
  • Macrolides*
  • Staphylococcus / drug effects
  • Staphylococcus / genetics*
  • Virginiamycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Lincosamides
  • Macrolides
  • Virginiamycin